PROTAC FLT-3 degrader 4
PROTAC FLT-3 degrader 4 is an orally active CRBN-based FLT3-PROTAC degrader that potently induces FLT3-ITD degradation through the ubiquitin-proteasome system. PROTAC FLT-3 degrader 4 shows highly selective to FLT3-ITD mutant acute myeloid leukemia (AML) cells. (Blue: CRBN ligand, Black: linker; Pink: FLT3 inhibitor).
For research use only. We do not sell to patients.
- CAS No.: 2956722-48-6
- Formula: C39H41FN8O6
- Molecular Weight:736.79
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All PROTACs Isoforms
More
Biological Activity
|
Cereblon |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| BaF3 | IC50 |
31.3 nM
Compound: A20
|
Antiproliferative activity against mouse Ba/F3 cells expressing FLT3-ITD D835Y mutant incubated for 48 hrs by CCK8 assay
Antiproliferative activity against mouse Ba/F3 cells expressing FLT3-ITD D835Y mutant incubated for 48 hrs by CCK8 assay
|
[PMID: 38655686] |
| BaF3 | IC50 |
45.1 nM
Compound: A20
|
Antiproliferative activity against mouse Ba/F3 cells expressing FLT3-ITD D835V mutant incubated for 48 hrs by CCK8 assay
Antiproliferative activity against mouse Ba/F3 cells expressing FLT3-ITD D835V mutant incubated for 48 hrs by CCK8 assay
|
[PMID: 38655686] |
| BaF3 | IC50 |
46.7 nM
Compound: A20
|
Antiproliferative activity against mouse Ba/F3 cells expressing FLT3-ITD Y842H mutant incubated for 48 hrs by CCK8 assay
Antiproliferative activity against mouse Ba/F3 cells expressing FLT3-ITD Y842H mutant incubated for 48 hrs by CCK8 assay
|
[PMID: 38655686] |
| BaF3 | IC50 |
66.2 nM
Compound: A20
|
Antiproliferative activity against mouse Ba/F3 cells expressing FLT3-ITD F691L mutant incubated for 48 hrs by CCK8 assay
Antiproliferative activity against mouse Ba/F3 cells expressing FLT3-ITD F691L mutant incubated for 48 hrs by CCK8 assay
|
[PMID: 38655686] |
| HL-60 | IC50 |
>40000 nM
Compound: A20
|
Antiproliferative activity against human HL-60 cells expressing wild-type FLT3 incubated for 48 hrs by CCK8 assay
Antiproliferative activity against human HL-60 cells expressing wild-type FLT3 incubated for 48 hrs by CCK8 assay
|
[PMID: 38655686] |
| MOLM-13 | IC50 |
147.4 nM
Compound: A20
|
Antiproliferative activity against Sunitinib-resistant human MOLM-13 cells incubated for 48 hrs by CCK8 assay
Antiproliferative activity against Sunitinib-resistant human MOLM-13 cells incubated for 48 hrs by CCK8 assay
|
[PMID: 38655686] |
| MOLM-13 | IC50 |
169.9 nM
Compound: A20
|
Antiproliferative activity against human MOLM-13 cells incubated for 48 hrs by CCK8 assay
Antiproliferative activity against human MOLM-13 cells incubated for 48 hrs by CCK8 assay
|
[PMID: 38655686] |
| MOLM-13 | IC50 |
483.6 nM
Compound: A20
|
Antiproliferative activity against Quizartinib-resistant human MOLM-13 cells incubated for 48 hrs by CCK8 assay
Antiproliferative activity against Quizartinib-resistant human MOLM-13 cells incubated for 48 hrs by CCK8 assay
|
[PMID: 38655686] |
| MV4-11 | IC50 |
39.9 nM
Compound: A20
|
Antiproliferative activity against human MV4-11 cells expressing FLT3-ITD mutant incubated for 48 hrs by CCK8 assay
Antiproliferative activity against human MV4-11 cells expressing FLT3-ITD mutant incubated for 48 hrs by CCK8 assay
|
[PMID: 38655686] |
| THP-1 | IC50 |
15117.5 nM
Compound: A20
|
Antiproliferative activity against human THP-1 cells expressing wild-type FLT3 incubated for 48 hrs by CCK8 assay
Antiproliferative activity against human THP-1 cells expressing wild-type FLT3 incubated for 48 hrs by CCK8 assay
|
[PMID: 38655686] |
| U-937 | IC50 |
>40000 nM
Compound: A20
|
Antiproliferative activity against human U-937 cells expressing wild-type FLT3 incubated for 48 hrs by CCK8 assay
Antiproliferative activity against human U-937 cells expressing wild-type FLT3 incubated for 48 hrs by CCK8 assay
|
[PMID: 38655686] |
PROTAC FLT-3 degrader 4 (compound A20) shows antiproliferative activities against MV4-11 and MOLM-13 cells (IC50 of 39.9 nM and 169.9 nM, respectively)[1].
PROTAC FLT-3 degrader 4 (0.25-100 nM; 24 h) demonstrates a substantial reduction in FLT3-ITD protein levels in MV4-11 and MOLM-13 cells[1].
PROTAC FLT-3 degrader 4 (20 nM; 12 h) inhibits FLT3-ITD phosphorylation and its downstream signal mediators including STAT5, S6K, and ERK in MV4-11 and MOLM-13 cells[1].
PROTAC FLT-3 degrader 4 (20 nM; 12 h) dose-dependently induces cycle arrest in the G1 phase. PROTAC FLT-3 degrader 4 also dose-dependently induces the apoptosis of MV4-11 and MOLM-13 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MV4-11 and MOLM-13 cells
-
Concentration:0.25 nM, 0.5 nM, 1 nM, 5 nM, 10 nM, 20 nM, 50 nM, 80 nM, 100 nM
-
Incubation Time:24 h
-
Result:Showed potent FLT3-ITD degradation activity with DC50 values of 7.4 nM and 20.1 nM for MV4-11 and MOLM-13 cells, respectively.
-
Cell Line:MV4-11 and MOLM-13 cells
-
Concentration:1 nM, 5 nM, 50 nM
-
Incubation Time:24 h
-
Result:Blocked AML cell cycle in G1 phase and induced apoptosis.
Pharmacokinetic Parameters of PROTAC FLT-3 degrader 4 in Sprague-Dawley rats[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Four week old male nu/nu mice injected with MV4-11 cells[1]
-
Dosage:1.25 mg/kg, 2.5 mg/kg, 5 mg/kg, 10 mg/kg
-
Administration:po; daily; for 2 weeks
-
Result:Significantly inhibited tumor growth at 1.25 mg/kg.
Chemical Information
-
CAS No. 2956722-48-6
-
Molecular Weight 736.79
-
Formula C39H41FN8O6
-
SMILES
O=C1NC2=CC=C(C=C2/C1=C/C3=C(C(NC(CN4CCN(CC4)CC5CCN(CC5)C6=CC=C7C(N(C(C7=C6)=O)C8CCC(NC8=O)=O)=O)=O)=CN3)C)F
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)